← Open Payments lookup

DAVID METHENY: Open Payments

NPI 1538391453 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,368 in 65 payments from 13 companies in 2025. Trend: 2023 $597 · 2024 $736 · 2025 $1,368

Food & beverage: $1,368
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$258
Teva Pharmaceuticals USA, Inc.11$202
ABBVIE INC.10$197
E.R. Squibb & Sons, L.L.C.4$178
Vanda Pharmaceuticals Inc.7$138
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$111
Alkermes, Inc.5$87
Otsuka America Pharmaceutical, Inc.3$54
Lundbeck LLC3$52
Takeda Pharmaceuticals U.S.A., Inc.2$29

Products named: INGREZZA, VRAYLAR, AUSTEDO XR, COBENFY, FANAPT, CAPLYTA, REXULTI, ARISTADA.

Industry payments across GA — which companies pay providers there.